Effect of Neurofeedback Training on Depression and Fatigue in Patients with Multiple Sclerosis

Choobforoushzadeh, Azadeh; Doost, Hamid Taher Neshat; Molavi, H; Abedi, Mohammad Reza

doi:10.1007/s10484-014-9267-4

Cited by 34 publications

(27 citation statements)

References 61 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The findings from this case series provide additional evidence suggesting that neurofeedback might be an effective method for helping some (and perhaps many) individuals with chronic pain learn self-management skills that would give them more control over, and alleviate, their suffering, and also result in improvements in other related symptoms and problems. This latter point is supported by the findings of Choobforoushzadeh, Neshat-Doost, Molavi, and Abedi (2015), who found that neurofeedback reduced symptoms of depression and fatigue in patients with multiple sclerosis. More research is also warranted to evaluate the efficacy of neurofeedback, relative to other pain treatments, to distinguish the specific from the nonspecific effects of neurofeedback, and to identify the training protocols that are most effective for patients with different pain conditions.…”

Section: Discussionsupporting

confidence: 58%

EEG Neurofeedback in the Treatment of Chronic Pain: A Case Series

Jacobs¹,

Jensen²

2015

NeuroRegulation

View full text Add to dashboard Cite

Neurofeedback has been used to treat a variety of problems and symptoms related to central nervous system dysregulation, including chronic pain conditions. However, there is limited published work describing the application and efficacy of neurofeedback for chronic pain. This case series describes the outcomes of neurofeedback treatment of four patients with diverse diagnoses and pain symptoms. Although there was variability in patient response, all patients reported improvements in pain and other symptoms with treatment. The findings indicate that more research to (1) clarify the benefits of neurofeedback for different conditions and (2) identify the most effective protocols for individual patients is warranted.

show abstract

Section: Discussionsupporting

confidence: 58%

EEG Neurofeedback in the Treatment of Chronic Pain: A Case Series

Jacobs¹,

Jensen²

2015

NeuroRegulation

View full text Add to dashboard Cite

show abstract

“…According to the investigation and the data obtained from the questionnaire, these results were as follows: EEG feedback therapy on quality of life in patients with multiple sclerosis in post-test and follow up Phase was effective. These findings indirectly coordinated with Choobforoushzadeh et al [19], Pampa Reddy et al [20], Hammond [21], Hammond [22]. Several studies regarding the effectiveness of EEG feedback therapy was conducted on patients with MS.…”

Section: Discussionsupporting

confidence: 67%

The Effect of EEG Biofeedback on Depression and Improve the Quality of Life of Patients With Multiple Sclerosis (MS)

Bidaki¹,

Sepehri²,

Mohammadi³

et al. 2017

Foc Sci

View full text Add to dashboard Cite

Introduction: Due to some physical and mental symptoms and failure to accept the reality, Multiple Sclerosis (MS) patients suffer from negative mood disorders and trauma, and this would have negative effects on their quality of life. This study aimed to investigate the effectiveness of EEG biofeedback on MS patients' quality of life and depression symptoms. Methods:The design is Quasi-experimental with pre-test, post-test and follow-up. The sample, 20 patients in experiment (10) and control (10) groups, is all of the MS patients of Yazd that have a record in clinics or MS Association, and is chosen by convenience sampling. Before the treatment started, patients had filled the HADS depression scale and MSQOL-54 quality of life questionnaire, then, in the post-test and follow-up stages, these evaluations were done again. The treatment lasted for 15 sessions, two sessions per week, and the follow-up was done three months after the post-test. The data obtained from the questionnaire were analyzed by SPSS17 software using descriptive tests (mean and standard deviation) and inferential tests (covariance analysis). Results: Research findings shows that EEG biofeedback decreases the depression level and increases the quality of life of patients with MS. Conclusions: MS results in many symptoms, and its sufferers may need a mental rehabilitation in future, therefore, EEG biofeedback can be applied by therapists as a complementary therapy in clinics and therapeutic centers.

show abstract

“…Among their 20 participants with MDD, 15% and 55% had remission of their condition at 4 weeks and 8 weeks, respectively. In a study of 24 people with multiple sclerosis who had significant depression and fatigue, Choobforoushzadeh, Neshat-Doost, Molavi, and Abedi (2015) provided half of participants with neurofeedback and the other half with "treatment as usual." Their neurofeedback protocol consisted of down-training theta and alpha waves, and up-training first beta and then SMR, at F3.…”

Section: Neurofeedback Trainingmentioning

confidence: 99%

Combined Neurofeedback and Heart Rate Variability Training for Individuals with Symptoms of Anxiety and Depression: A Retrospective Study

White¹,

Groeneveld²,

Tittle³

et al. 2017

View full text Add to dashboard Cite

Introduction.Neurofeedback (NFB) and heart rate variability (HRV) training present promising, nonpharmaceutical intervention strategies for anxiety and depression. This report is the first to address whether concurrent NFB and HRV (NFB+HRV) provides a viable intervention for symptoms of anxiety and depression, measured by the Achenbach System of Empirically Based Assessment (ASEBA) questionnaire. Methods. 183 children and adults with symptoms of anxiety and/or depression underwent NFB+HRV training. Psychological symptom rating, EEG, blood pressure, breathing pattern, and HRV were measured before and after treatment. Results. After NFB+HRV training, symptoms of anxiety (p < .001, d z = 1.42) and depression (p < .001, d z = 1.34) were reduced in children and adults. The majority of individuals with pretreatment symptoms of anxiety (82.8%) or depression (81.1%) experienced ASEBA improvements of clinical importance. There were also significant changes in EEG, breathing rate, and HRV. For the 16 individuals copresenting with hypertension, systolic and diastolic blood pressure were significantly reduced. Conclusion. We present evidence that NFB+HRV training may provide an effective, nonpharmaceutical intervention to reduce symptoms of anxiety and depression in children and adults. Additionally, NFB+HRV training may improve EEG, blood pressure, resting breathing rate, and HRV.

show abstract

Effect of Neurofeedback Training on Depression and Fatigue in Patients with Multiple Sclerosis

Cited by 34 publications

References 61 publications

EEG Neurofeedback in the Treatment of Chronic Pain: A Case Series

EEG Neurofeedback in the Treatment of Chronic Pain: A Case Series

The Effect of EEG Biofeedback on Depression and Improve the Quality of Life of Patients With Multiple Sclerosis (MS)

Combined Neurofeedback and Heart Rate Variability Training for Individuals with Symptoms of Anxiety and Depression: A Retrospective Study

Contact Info

Product

Resources

About